-
公开(公告)号：EP2976331B1
公开(公告)日：2017-03-01
申请号：EP14710915.1
申请日：2014-03-19
发明人： HENKEL, Bernd
IPC分类号： C07D233/72 , C07K5/00 , C07K14/00
CPC分类号： C07K14/47 , C07D233/78 , C07K1/04 , C07K1/107
-
公开(公告)号：EP3080149A1
公开(公告)日：2016-10-19
申请号：EP14825276.0
申请日：2014-12-11
申请人： SANOFI
发明人： HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , STENGELIN, Siegfried , EVERS, Andreas , BOSSART, Martin , KADEREIT, Dieter
IPC分类号： C07K14/575 , C07K14/605
CPC分类号： A61K38/26 , A61K45/06 , C07K14/57563 , C07K14/605
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake
摘要翻译： 本发明涉及毒蜥外泌肽-4衍生物及其医疗用途，例如用于治疗代谢综合征疾病，包括糖尿病和肥胖症，以及减少过量食物摄入
-
公开(公告)号：EP3080150B1
公开(公告)日：2018-08-01
申请号：EP14828149.6
申请日：2014-12-11
申请人： SANOFI
发明人： KADEREIT, Dieter , LORENZ, Katrin , EVERS, Andreas , HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , LORENZ, Martin , STENGELIN, Siegfried
IPC分类号： C07K14/575 , C07K14/605
CPC分类号： A61K38/26 , A61K45/06 , C07K14/57563 , C07K14/605
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
-
公开(公告)号：EP3157949B1
公开(公告)日：2018-07-18
申请号：EP15731876.7
申请日：2015-06-17
申请人： SANOFI
IPC分类号： C07K14/575 , A61K38/22 , A61P3/10
CPC分类号： C07K14/605 , A61K38/00 , A61K45/06 , C07K14/57563
摘要： The present invention relates to glucagon receptor agonists and their medical use, for example in the treatment of severe hypoglycemia.
-
公开(公告)号：EP2934569A1
公开(公告)日：2015-10-28
申请号：EP13814892.9
申请日：2013-12-19
申请人： SANOFI
发明人： HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , STENGELIN, Siegfried , EVERS, Andreas , LORENZ, Martin , LORENZ, Katrin
IPC分类号： A61K38/26 , C07K14/605
CPC分类号： C07K14/605 , A61K9/0019 , A61K38/00 , A61K38/2264 , A61K38/26 , A61K38/28 , A61K45/06 , Y02A50/401 , A61K2300/00
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
摘要翻译： 本发明涉及毒蜥外泌肽-4衍生物及其医学用途，例如用于治疗包括糖尿病和肥胖在内的代谢综合征病症以及减少过量食物摄入。
-
公开(公告)号：EP2934567B9
公开(公告)日：2018-08-22
申请号：EP13810958.2
申请日：2013-12-19
申请人： SANOFI
发明人： HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , STENGELIN, Siegfried , EVERS, Andreas , LORENZ, Martin , LORENZ, Katrin
CPC分类号： C07K14/605 , A61K9/0019 , A61K38/00 , A61K38/2264 , A61K38/26 , A61K38/28 , A61K45/06 , Y02A50/401 , A61K2300/00
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
-
公开(公告)号：EP2906595B1
公开(公告)日：2017-08-16
申请号：EP13773767.2
申请日：2013-10-08
申请人： SANOFI
发明人： HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , STENGELIN, Siegfried , EVERS, Andreas , BOSSART, Martin
CPC分类号： A61K38/26 , A61K38/00 , A61K38/2264 , A61K38/28 , A61K45/06 , C07K14/605 , Y02A50/401 , A61K2300/00
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
摘要翻译： 本发明涉及毒蜥外泌肽-4衍生物及其医学用途，例如用于治疗包括糖尿病和肥胖在内的代谢综合征病症以及减少过量食物摄入。
-
8.发明公开EXENDIN-4 PEPTIDE ANALOGUES AS DUAL GLP-1/GIP RECEPTOR AGONISTS 审中-公开维生素D-PEPTIDANALOGA ALS DUAGA GLP-1 / GIP-REZEPTORAGONISTEN
公开(公告)号：EP3080150A1
公开(公告)日：2016-10-19
申请号：EP14828149.6
申请日：2014-12-11
申请人： Sanofi
发明人： KADEREIT, Dieter , LORENZ, Katrin , EVERS, Andreas , HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , LORENZ, Martin , STENGELIN, Siegfried
IPC分类号： C07K14/575 , C07K14/605
CPC分类号： A61K38/26 , A61K45/06 , C07K14/57563 , C07K14/605
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
摘要翻译： 本发明涉及毒蜥外泌肽-4衍生物及其医疗用途，例如用于治疗代谢综合征疾病，包括糖尿病和肥胖症，以及减少过量食物摄入
-
公开(公告)号：EP2934567A1
公开(公告)日：2015-10-28
申请号：EP13810958.2
申请日：2013-12-19
申请人： SANOFI
发明人： HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , STENGELIN, Siegfried , EVERS, Andreas , LORENZ, Martin , LORENZ, Katrin
IPC分类号： A61K38/26 , C07K14/605
CPC分类号： C07K14/605 , A61K9/0019 , A61K38/00 , A61K38/2264 , A61K38/26 , A61K38/28 , A61K45/06 , Y02A50/401 , A61K2300/00
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
摘要翻译： 本发明涉及毒蜥外泌肽-4衍生物及其医学用途，例如用于治疗包括糖尿病和肥胖在内的代谢综合征病症以及减少过量食物摄入。
-
10.发明公开EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS 有权EXENDIN-4衍生物作为双重GLP1 / GIP或TRIGONAL GLP1 / GIP / GLUCAGON激动剂
公开(公告)号：EP2934566A1
公开(公告)日：2015-10-28
申请号：EP13810957.4
申请日：2013-12-19
申请人： SANOFI
发明人： HAACK, Torsten , WAGNER, Michael , HENKEL, Bernd , STENGELIN, Siegfried , EVERS, Andreas , LORENZ, Martin , LORENZ, Katrin
IPC分类号： A61K38/26 , C07K14/605
CPC分类号： C07K14/605 , A61K9/0019 , A61K38/00 , A61K38/2264 , A61K38/26 , A61K38/28 , A61K45/06 , Y02A50/401 , A61K2300/00
摘要： The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
摘要翻译： 本发明涉及毒蜥外泌肽-4衍生物及其医学用途，例如用于治疗包括糖尿病和肥胖在内的代谢综合征病症以及减少过量食物摄入。
-
-
-
-
-
-
-
-
-
搜索结果
29 条记录 (耗时 0.02 秒)
